NPI: 1316901440 · FEDERAL WAY, WA 98003 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,833 | $371K |
| 2019 | 11,989 | $391K |
| 2020 | 16,516 | $564K |
| 2021 | 17,034 | $506K |
| 2022 | 17,442 | $497K |
| 2023 | 10,667 | $590K |
| 2024 | 6,383 | $606K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 39,457 | 2,758 | $2.89M |
| A4657 | Syringe, with or without needle, each | 4,087 | 1,781 | $514K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,892 | 1,416 | $75K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 791 | 397 | $30K |
| J1756 | Injection, iron sucrose, 1 mg | 6,503 | 1,466 | $18K |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,657 | 738 | $2K |
| 90674 | 53 | 43 | $233.52 | |
| 0004A | 18 | 15 | $45.04 | |
| G0008 | Administration of influenza virus vaccine | 105 | 86 | $34.44 |
| 0001A | 16 | 15 | $16.94 | |
| 83970 | 1,033 | 758 | $0.00 | |
| 83540 | 663 | 515 | $0.00 | |
| 85041 | 1,516 | 1,127 | $0.00 | |
| 85048 | 1,511 | 1,125 | $0.00 | |
| 82108 | 70 | 51 | $0.00 | |
| 0002A | 14 | 14 | $0.00 | |
| 90661 | 13 | 13 | $0.00 | |
| 83550 | 511 | 416 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 265 | 137 | $0.00 |
| 82728 | 649 | 512 | $0.00 | |
| 82607 | 21 | 13 | $0.00 | |
| 82746 | 19 | 12 | $0.00 |